Kyiv based Darnytsia pharmaceutical company placed A and C bonds for UAH 459mln with a par value of UAH 300mln. The placement took place at Ukraine’s PFTS stock exchange. The underwriter of the deal was Ukrsibbank (Kharkiv). The bonds mature in ten years in July 2025. The interest of quarterly coupon yield is at annual interest of 30%. Initially, Darnytsia planned to place a total of UAH 1bn of bonds in A-C, D-F, and G-J bonds. The company will channel UAH 500mln into purchase of intellectual property rights. Darnytsia is among top ten deliverers of medicines to hospitals in Ukraine. In H1/2016, Darnytsia posted a net profit of UAH 144mln, down 49% y/y. Mr. Gleb Zagoriy remains a major shareholder of the company.
Domestic pharmaceutical Darnytsia places UAH 459mln (USD 18mln) bonds
The local pharmaceutical major placed A and C series bonds
Fill in the contact details to receive the monthly newsletter!